Use the Back button in your browser to see the other results of your search or to select another record.
| The efficacy of intermittent pneumatic compression and negative pressure therapy on muscle function, soreness and serum indices of muscle damage: a randomized controlled trial |
| Wiecha S, Jarocka M, Wisniowski P, Cieslinski M, Price S, Makaruk B, Kotowska J, Drabarek D, Cieslinski I, Sacewicz T |
| BMC Sports Science, Medicine and Rehabilitation 2021 Nov 13;13(144):Epub |
| clinical trial |
| 7/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
BACKGROUND: The study aimed to assess whether intermittent pneumatic compression (IPC) and intermittent negative pressure (INP) would attenuate the muscle damaging effects of eccentric exercise. METHODS: Forty-five healthy males were recruited. Immediately post, 24 and 48 h post eccentric exercise consisting of 100 drop jumps, volunteers randomly received 30-min sessions of intermittent pneumatic compression (IPC, n = 15) or intermittent negative pressure (INP, n = 15), or sham microcurrent (PT, n = 15). Creatine kinase (CK), lactate dehydrogenase (LDH), isokinetic muscle strength, soreness and active flexion of the knee joint were measured after every therapy session. RESULTS: No significant intergroup differences were observed in biochemical or functional measurements. However, there was an increase in muscle soreness (p < 0.05), CK and LDH activity (p < 0.05), and a reduction in muscle strength (p < 0.05) and range of active knee flexion (p < 0.05). CONCLUSIONS: The prescription of IPC and INP did not attenuate the reduction of markers to muscle function or pain perception up to 48 h after muscle damaging exercise. Future research should focus on the potential impact of treatment frequency and duration on muscle recovery. TRIAL REGISTRATION: The study was retrospectively registered in the Australian New Zealand Clinical Trials Registry ACTRN12621001294842, 24/09/2021.
|